Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E24.71 EPS (ttm)6.65 Insider Own0.08% Shs Outstand2.67B Perf Week-0.24%
Market Cap433.99B Forward P/E14.02 EPS next Y11.72 Insider Trans0.00% Shs Float2.63B Perf Month-5.66%
Income17.77B PEG2.78 EPS next Q2.36 Inst Own69.50% Short Float0.66% Perf Quarter0.09%
Sales89.19B P/S4.87 EPS this Y-4.20% Inst Trans0.63% Short Ratio2.90 Perf Half Y-0.35%
Book/sh26.04 P/B6.31 EPS next Y5.26% ROA10.20% Target Price187.17 Perf Year13.61%
Cash/sh9.58 P/C17.15 EPS next 5Y8.89% ROE27.00% 52W Range133.65 - 179.92 Perf YTD4.44%
Dividend4.24 P/FCF36.79 EPS past 5Y-0.30% ROI14.60% 52W High-8.65% Beta0.71
Dividend %2.58% Quick Ratio1.10 Sales past 5Y3.30% Gross Margin67.10% 52W Low22.98% ATR2.16
Employees134500 Current Ratio1.40 Sales Q/Q27.10% Oper. Margin22.60% RSI (14)32.61 Volatility1.28% 1.22%
OptionableYes Debt/Eq0.48 EPS Q/Q72.70% Profit Margin19.90% Rel Volume0.73 Prev Close164.86
ShortableYes LT Debt/Eq0.44 EarningsOct 19 BMO Payout60.90% Avg Volume5.96M Price164.36
Recom2.10 SMA20-2.72% SMA50-4.25% SMA200-0.39% Volume4,382,017 Change-0.30%
Sep-07-21Downgrade Morgan Stanley Overweight → Equal-Weight $187
May-28-21Resumed Morgan Stanley Overweight $187
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Sep-26-21 08:15AM  
06:10AM  
Sep-25-21 06:04AM  
Sep-24-21 03:14PM  
02:07PM  
02:02PM  
01:27PM  
12:20PM  
11:27AM  
11:15AM  
10:37AM  
08:52AM  
08:27AM  
06:53AM  
06:00AM  
Sep-23-21 09:33PM  
09:00PM  
06:17PM  
10:15AM  
08:16AM  
06:31AM  
06:03AM  
06:00AM  
06:00AM  
Sep-22-21 08:38PM  
05:45PM  
01:43PM  
11:44AM  
06:15AM  
06:00AM  
Sep-21-21 11:33PM  
10:05PM  
05:47PM  
05:31PM  
04:12PM  
01:41PM  
01:20PM  
01:18PM  
12:27PM  
12:19PM  
11:11AM  
10:47AM  
10:30AM  
10:09AM  
08:14AM  
07:25AM  
06:57AM  
06:42AM  
06:30AM  
06:30AM  
05:50AM  
04:21AM  
03:34AM  
02:46AM  
Sep-20-21 04:50PM  
04:14PM  
03:29PM  
02:23PM  
01:42PM  
12:09PM  
12:01PM  
11:50AM  
10:38AM  
08:16AM  
Sep-19-21 01:29PM  
12:29PM  
07:21AM  
Sep-18-21 10:41AM  
10:34AM  
Sep-17-21 04:41PM  
03:59PM  
03:56PM  
03:40PM  
03:34PM  
02:29PM  
02:09PM  
12:34PM  
11:34AM  
09:45AM  
07:00AM  
05:52AM  
Sep-16-21 05:54PM  
05:45PM  
05:19PM  
02:06PM  
10:54AM  
10:50AM  
10:36AM  
09:51AM  
09:31AM  
09:15AM  
Sep-15-21 05:00PM  
02:40PM  
01:51PM  
12:51PM  
11:45AM  
10:53AM  
08:49AM  
Sep-13-21 11:00PM  
07:33PM  
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusVice Chair, Exec CommitteeFeb 12Option Exercise0.0035,0620289,864Feb 17 07:09 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 12Option Exercise0.0013,6060121,191Feb 17 07:09 PM
Ullmann Michael HExec VP, General CounselFeb 12Option Exercise0.0014,4440157,728Feb 17 07:09 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 12Option Exercise0.0010,362068,837Feb 17 07:09 PM
Wolk Joseph JExec VP, CFOFeb 12Option Exercise0.005,086024,513Feb 17 07:09 PM
Decker Robert JController, CAOFeb 12Option Exercise0.001,310014,701Feb 17 07:09 PM
Gorsky AlexChairman, CEOFeb 12Option Exercise0.0075,1050507,925Feb 17 07:09 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 12Option Exercise0.007,145042,960Feb 17 07:09 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 12Option Exercise0.0033,0210209,490Feb 17 07:09 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12Option Exercise0.0012,8730113,039Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & CCOFeb 12Option Exercise0.009,211065,290Feb 17 07:09 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 12Option Exercise0.0013,136034,834Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Option Exercise62.2054,6623,399,976110,741Dec 10 06:19 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Sale152.9354,6628,359,46056,079Dec 10 06:19 PM